Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients

Stroke

Volumn 27, Issue 6, 1996, Pages 1044-1049

  Baldassarre, Damiano ^a   Tremoli, Elena ^a   Franceschini, Guido ^a   Michelagnoli, Silvia ^a   Sirtori, C R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

atherosclerosis; carotid arteries; lipoproteins, LDL cholesterol

Indexed keywords

CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERY OBSTRUCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030000045     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.6.1044     Document Type: Article

References (41)

1. Loscalzo J. Lipoprotein(a): a unique risk factor for atherothrombotic disease. Arteriosclerosis. 1990;10:672-679.
2. Utermann G. The mystery of lipoprotein(a). Science. 1989;246: 904-910.
3. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentration and angiographically assessed coronary atherosclerosis. Atherosclerosis. 1986;62:249-257.
4. Houlston R, Quiney J, Mount J, Watts GF, Lewis B. Lipoprotein(a) and coronary heart disease in familial hypercholesterolaemia. Lancet. 1988;2:405. Letter.
5. Wiklund O, Angelin B, Olofsson S-O, Eriksson M, Fager G, Berglund L, Bondjers G. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet. 1990;335:1360-1363.
6. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intima plus media thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
7. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the quantitation and follow-up of pre-clinical atherosclerosis in living human subjects. Atherosclerosis. 1988;70:253-261.
8. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis. 1990;81:33-41.
9. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med. 1991;229:225-231.
10. Wendelhag I, Wiklund O, Wikstrand J. Arterial wall thickness in familial hypercholesterolemia: ultrasound measurement of intima-media thickness in common carotid artery. Arterioscler Thromb. 1992;12:70-77.
11. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993; 87(suppl II):II-56-II-65.
12. Bots ML, Hofmann A, De Bruyn AM, De Jong PTVM, Grobbee DE. Isolated systolic hypertension and vessel wall thickness of the carotid artery: the Rotterdam Elderly Study. Arterioscler Thromb. 1993;13:64-69.
13. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size and physical activity. Stroke. 1994;25:66-73.
14. Jovicic A, Ivanisevic V, Ivanovic I. Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders. Atherosclerosis. 1993;98:59-65.
15. Schreiner PJ, Morrisett JD, Sharrett AR, Patsch W, Tyroler HA, Wu K, Heiss G. Lipoprotein(a) as a risk factor for preclinical atherosclerosis. Arterioscler Thromb. 1993;13:826-833.
16. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1993;13:1558-1566.
17. Cambillau M, Simon A, Amar J, Giral Ph, Atger V, Segond P, Levenson J, Merli I, Megnien JL, Plainfosse MC, Moatti N, PCVMETRA Group. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extra-coronary sites in hypercholesterolemic men. Arterioscler Thromb. 1992;12:1346-1352.
18. Tatò F, Keller C, Schuster H, Spengel F, Wolfram G, Zollner N. Relation of lipoprotein(a) to coronary heart disease and duplex sonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia. Atherosclerosis. 1993;101:69-77.
19. Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T. Classification of hyperlipidemias and hyperlipoproteinemias. World Health Organ Bull. 1970;43:891-915.
20. Bucolo G, David M. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem. 1973;19:476-482.
21. Warnick GR, Benderson J, Albers JJ. Dextran sulfate precipitation procedure for quantitation of high density lipoproteins. Clin Chem. 1982;28:1379-1388.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
23. Werba JP, Safa O, Gianfranceschi G, Michelagnoli S, Sirtori CR, Franceschini G. Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population. Atherosclerosis. 1993;101:203-211.
24. Baldassarre D, Werba JP, Tremoli E, Poli A, Pazzucconi F, Sirtori C. Common carotid intima-media thickness measurement: a method to improve accuracy and precision. Stroke. 1994;25: 1588-1592.
25. Dahlen G, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74:758-765.
26. Liu AC, Lawn RM. Lipoprotein(a) and atherogenesis. Trends Cardiovasc Med. 1994;4:40-44.
27. Rankinen T, Valsanen S, Mercuri M, Rauramaa R. Apolipoprotein(a), fibrinopeptide A and carotid atherosclerosis in middle-aged men. Thromb Haemost. 1994;72:563-566.
28. Margitic SE, Bond MG, Crouse JR, Furberg CD, Probstfield JL. Progression and regression of carotid atherosclerosis in clinical trials. Arterioscler Thromb. 1991;11:443-451.
29. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation. 1990;82:1230-1242.
30. Bruckert E, Giral P, Salloum J, Kahan JF, Dairou F, Truffert J, Reverdy V, Thomas D, Evans J, Grosgogeat Y, De Gennes JL. Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population. Atherosclerosis. 1992;92:105-114.
31. Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM Jr. Relationship of plasma lipoprotein(a) levels to race and to apolipoprotein B. Arteriosclerosis. 1985;5:265-272.
32. Soma MR, Fumagalli R, Paoletti R, Meschia M, Maini MC, Crosignani P, Ghanem K, Gaubatz J, Morrisett JP. Plasma Lp(a) concentrations after estrogen and progesterone in postmenopausal women. Lancet. 1991;337:612. Letter.
33. Soma MR, Osnago-Gadda I, Fumagalli R, Morrisett JD, Meschia M, Crosignani P. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med. 1993;153:1462-1468.
34. Henriksson P, Angelin B, Berglund L. Hormonal regulation of serum Lp(a) levels: opposite effects after estrogen treatment and orchiectomy in males with prostatic carcinoma. J Clin Invest. 1992; 89:1166-1171.
35. Haffner SM, Gruber KK, Morales PA, Hazuda HP, Valdez RA, Mitchell BD, Stern MP. Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol. 1992;136:1060-1068.
36. Schriewer H, Assmann G, Sandkamp M, Schulte H. The relationship of lipoprotein(a) (Lp[a]) to risk factors of coronary heart disease: initial results of the prospective epidemiology study on company employees in Westfalia. J Clin Chem Biochem. 1984;22: 591-596.
37. Haffner SM, Mykkanen L, Gruber KK, Rainwater DL, Laakso M. Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men. Arterioscler Thromb. 1994; 14:19-24.
38. Hajjar D, Gavish D, Breslow JL, Nachman RL. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 1989;339:303-305.
39. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature. 1994;370:460-462.
40. Rath M, Niendorf A, Reblin T, Dietel M, Krebber H-J, Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989;9:579-592.
41. Maher VMG, Brown GB, Marcovina SM, Hillger LA, Zhao XO, Albers JJ. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA. 1995;274:1771-1774.